Psychosis and schizophrenia | Guidance and guideline topic | NICE

Everything NICE has produced on the topic of psychosis and schizophrenia. Includes related guidelines, NICE Pathways, quality standards and advice.

0 new

and

0 updated

products since February 2017.

There is in progress.

NICE Pathways - mapping our guidance

Technology appraisal guidance

Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (TA213) January 2011
Guidance on the use of electroconvulsive therapy (TA59) April 2003
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) (TA286) May 2013
Structural neuroimaging in first-episode psychosis (TA136) February 2008

Quality standards

Bipolar disorder, psychosis and schizophrenia in children and young people (QS102) October 2015
Psychosis and schizophrenia in adults (QS80) February 2015

NICE Guidelines

NICE Evidence summaries

Schizophrenia: aripiprazole prolonged-release suspension for injection (ESNM39) March 2014
Schizophrenia: lurasidone (ESNM48) September 2014
Schizophrenia: omega-3 fatty acid medicines (ESUOM19) September 2013